Wordt geladen...
Cerebrospinal fluid GAP-43 in early multiple sclerosis
BACKGROUND/OBJECTIVE: Novel biomarkers identifying and predicting disease activity in multiple sclerosis (MS) would be valuable for primary diagnosis and as outcome measures for monitoring therapeutic effects in clinical trials. Axonal loss is present from the earliest stages of MS and correlates wi...
Bewaard in:
| Gepubliceerd in: | Mult Scler J Exp Transl Clin |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081760/ https://ncbi.nlm.nih.gov/pubmed/30094057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217318792931 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|